A

Alector

270 employees

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.

Investor insights

Sectors invested in

Medical1
Biotechnology1
Industrial1
Commercial1

Funding rounds participated in

$8.2M sweet spot round size

Most of their 1 investments are in rounds between $8.2M and $8.2M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Neurodegeneration
Therapeutics
Genetics
Neurodegenerative disease
Immuno-neurology

Date founded

2013

Investments made

I

INmune Bio Inc. raised $8.2M on February 7, 2019

Investors: Alector

FAQ